Living with bodily changes in hormone-refractory prostate cancer

Seminars in Oncology Nursing

Volumn 27, Issue 4, 2011, Pages 309-316

  Lindqvist, Olav ^a  

^a Stockholms Sjukhem Foundation   (Sweden)

Author keywords

Death and dying; Fatigue; Hormone refractory prostate cancer; Nursing; Pain; Palliative care; Prostate cancer; Symptoms

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AGED; ARTICLE; HUMAN; MALE; MIDDLE AGED; NURSING; PATHOPHYSIOLOGY; PROSTATE TUMOR; QUALITY OF LIFE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 80055094764     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2011.07.009     Document Type: Article

References (60)

1. Payne S., Seymour J., Ingleton C. Palliative care nursing: principles and evidence for practice 2008, Open University Press, Maidenhead, Berkshire, UK. 2nd edition.
2. Matzo M., Witt Sherman D. Palliative care nursing: quality care to the end of life 2010, Springer Publishing, New York. 3rd edition.
3. Gronberg H. Prostate cancer epidemiology. Lancet 2003, 361:859-864.
4. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
5. Socialstyrelsen. Cancer incidence in Sweden 2009 - official statistics of Sweden, health and medical care. 2010. Available at: (accessed October 1, 2011). http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18204/2010-12-17.pdf.
6. Regional oncologic center uppsala/örebroregionen. The national prostate cancer register (npcr) - in Sweden. Available at: (accessed october 1, 2011). http://www.roc.se.
7. Socialstyrelsen. Causes of death 2008 - official statistics of Sweden, health and medical care. 2010. Available at: (accessed October 1, 2011). http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18014/2010-4-31.pdf.
8. Sharifi N., Gulley J.L., Dahut W.L. Androgen deprivation therapy for prostate cancer. JAMA 2005, 294:238-244.
9. Goodin S., Rao K.V., DiPaola R.S. State-of-the-art treatment of metastatic hormone-refractory prostate cancer. Oncologist 2002, 7:360-370.
10. Wang M.C., Valenzuela L.A., Murphy G.P., et al. Purification of a human prostate specific antigen. Invest Urol 1979, 17:159-163.
11. Oh W.K., Kantoff P.W. Management of hormone refractory prostate cancer: current standards and future prospects. J Urol 1998, 160:1220-1229.
12. Kantoff P.W., Halabi S., Conaway M., et al. Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group b 9182 study. J Clin Oncol 1999, 17:2506-2513.
13. Tannock I.F., Osoba D., Stockler M.R., et al. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a canadian randomized trial with palliative end points. J Clin Oncol 1996, 14:1756-1764.
14. Petrylak D.P., Tangen C.M., Hussain M.H., et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004, 351:1513-1520.
15. Tannock I.F., de Wit R., Berry W.R., et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004, 351:1502-1512.
16. Sharifi N. New agents and strategies for the hormonal treatment of castration-resistant prostate cancer. Expert Opin Investig Drugs 2010, 19:837-846.
17. Seruga B., Ocana A., Tannock I.F. Drug resistance in metastatic castration-resistant prostate cancer. Nat Rev Clin Oncol 2011, 8:12-23.
18. Di Lorenzo G., Buonerba C., Autorino R., et al. Castration-resistant prostate cancer: current and emerging treatment strategies. Drugs 2010, 70:983-1000.
19. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet 2000, 355:1491-1498. Prostate Cancer Trialists' Collaborative G.
20. Clarke N.W. Management of the spectrum of hormone refractory prostate cancer. Eur Urol 2006, 50:428-438.
21. DiGiacomo S.M. Metaphor as illness: postmodern dilemmas in the representation of body, mind and disorder. Med Anthropol 1992, 14:109-137.
22. Corbin J.M. The body in health and illness. Qual Health Res 2003, 13:256-267.
23. Frank A.W. At the will of the body: Reflections on illness 1991, Houghton Mifflin, Boston, MA.
24. Armstrong T.S. Symptoms experience: a concept analysis. Oncol Nurs Forum 2003, 30:601-606.
25. Keating N.L., O'Malley A.J., Smith M.R. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006, 24:4448-4456.
26. Schwandt A., Garcia J.A. Complications of androgen deprivation therapy in prostate cancer. Curr Opin Urol 2009, 19:322-326.
27. Heidenreich A., von Knobloch R., Hofmann R. Current status of cytotoxic chemotherapy in hormone refractory prostate cancer. Eur Urol 2001, 39:121-130.
28. Esper P., Redman B.G. Supportive care, pain management, and quality of life in advanced prostate cancer. Urol Clin North Am 1999, 26:375-389.
29. Khafagy R., Shackley D., Samuel J., et al. Complications arising in the final year of life in men dying from advanced prostate cancer. J Palliat Med 2007, 10:705-711.
30. Penson D.F., Litwin M.S. The physical burden of prostate cancer. Urol Clin North Am 2003, 30:305-313.
31. Bryant-Lukosius D., Browne G., DiCenso A., et al. Evaluating health-related quality of life and priority health problems in patients with prostate cancer: a strategy for defining the role of the advanced practice nurse. Can Oncol Nurs J 2010, 20:5-14.
32. Eton D.T., Shevrin D.H., Beaumont J., et al. Constructing a conceptual framework of patient-reported outcomes for metastatic hormone-refractory prostate cancer. Value Health 2010, 13:613-623.
33. Navon L., Morag A. Advanced prostate cancer patients' ways of coping with the hormonal therapy's effect on body, sexuality, and spousal ties. Qual Health Res 2003, 13:1378-1392.
34. Navon L., Morag A. Liminality as biographical disruption: Unclassifiability following hormonal therapy for advanced prostate cancer. Soc Sci Med 2004, 58:2337-2347.
35. Oliffe J. Embodied masculinity and androgen deprivation therapy. Sociol Health Illn 2006, 28:410-432.
36. Clark J.A., Wray N., Brody B., et al. Dimensions of quality of life expressed by men treated for metastatic prostate cancer. Soc Sci Med 1997, 45:1299-1309.
37. Jakobsson L., Hallberg I.R., Loven L. Experiences of daily life and life quality in men with prostate cancer. An explorative study. Part i. Eur J Cancer Care 1997, 6:108-116.
38. Harden J., Schafenacker A., Northouse L., et al. Couples' experiences with prostate cancer: focus group research. Oncol Nurs Forum 2002, 29:701-709.
39. Chapple A., Ziebland S. Prostate cancer: Embodied experience and perceptions of masculinity. Sociol Health Illn 2002, 24:820-841.
40. Lindqvist O., Rasmussen B.H., Widmark A. Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases. Eur J Oncol Nurs 2008, 12:283-290.
41. Lindqvist O., Rasmussen B.H., Widmark A., et al. Time and bodily changes in advanced prostate cancer: Talk about time as death approaches. J Pain Symptom Manage 2008, 36:648-656.
42. Lindqvist O., Widmark A., Rasmussen B.H. Reclaiming wellness-living with bodily problems, as narrated by men with advanced prostate cancer. Cancer Nurs 2006, 29:327-337.
43. Lindqvist O., Widmark A., Rasmussen B.H. Meanings of the phenomenon of fatigue as narrated by 4 patients with cancer in palliative care. Cancer Nurs 2004, 27:237-243.
44. Cella D.F., Tulsky D.S., Gray G., et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993, 11:570-579.
45. Esper P., Mo F., Chodak G., et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 1997, 50:920-928.
46. Lindqvist O. Att leva med kroppsliga förändringar vid obotlig cancersjukdom med fokus på prostatacancer: " Jag är frisk - bortsett från att jag har cancer som är dödlig, men det är liksom en annan sak" Diss. Umeå universitet 2007, Umeå universitet, Umeå, [in Swedish].
47. Corner J., Dunlop R. New approaches to care. New themes in palliative care 1997, 288-302. Open University Press, Buckingham, UK. D. Clark, J. Hockey, S. Ahmedzai (Eds.).
48. Good B., Delvecchio Good M. The meaning of symptoms: a cultural hermeneutic model for clinical practice. The relevance of social science for medicine 1980, 165-196. D. Reidel Publishing, Dordrecht, The Netherlands. L. Eisenberg, A. Kleinman (Eds.).
49. McClement S.E., Woodgate R.L., Degner L. Symptom distress in adult patients with cancer. Cancer Nurs 1997, 20:236-243.
50. Haberman M. The measurement of symptom distress. Cancer symptom management 1999, 10-19. Jones & Bartlett, Boston, MA. C.H. Yarbro, M.H. Frogge, M. Goodman (Eds.).
51. Krishnasamy M. Fatigue in advanced cancer - meaning before measurement?. Int J Nurs Stud 2000, 37:401-414.
52. Corner J. Working with difficult symptoms. Palliative care nursing: principles and evidence for practice 2008, 232-251. Open University Press, Maidenhead, Berkshire, UK. 2nd edition. S. Payne, J. Seymour, C. Ingleton (Eds.).
53. Lindqvist O. Att leva med kroppsliga förändringar vid obotlig cancersjukdom. Omsorg: Nordisk Tidsskrift for Palliativ Medisin 2008, 25:19-23. [in Swedish].
54. Lindqvist O., Rasmussen B.H. Omvårdnad i livets slutskede. Omvårdnadens grunder: Hälsa och ohälsa 2009, 793-835. Studentlitteratur, Lund, [in Swedish]. A.K. Edberg, H. Wijk (Eds.).
55. Paterson B.L. The shifting perspectives model of chronic illness. J Nurs Scholarsh 2001, 33:21-26.
56. Paterson B.L. The koala has claws: applications of the shifting perspectives model in research of chronic illness. Qual Health Res 2003, 13:987-994.
57. Rasmussen B.H., Tishelman C., Lindqvist O. Experiences of living with a deteriorating body in late palliative phases of cancer. Curr Opin Support Palliat Care 2010, 4:153-157.
58. Cannaerts N., Dierckx de Casterle B., Grypdonck M. Palliative care, care for life: a study of the specificity of residential palliative care. Qual Health Res 2004, 14:816-835.
59. Rustøen T., Gaardsrud T., Leegaard M., et al. Nursing pain management-a qualitative interview study of patients with pain, hospitalized for cancer treatment. Pain Manage Nurs 2009, 10:48-55.
60. Kellehear A. Preface. The study of dying: from autonomy to transformation 2009, xiii-xiv. Cambridge University Press, Cambridge, UK. A. Kellehear (Ed.).